Fig. 4From: A field bioassay for assessing ivermectin bio-efficacy in wild malaria vectorsMedian survival times of An. gambiae s.s treated with high (85Â ng/ml), intermediate (43Â ng/ml) and low concentration (21Â ng/ml) of IVM administered in blood and in 1:4 blood-glucose mixtureBack to article page